Long shot : vaccines for national defense / Kendall Hoyt.

By: Material type: TextTextPublication details: Cambridge, Mass. : Harvard University Press, 2011.Description: xi, 300 pages : illustrations ; 25 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9780674061583
  • 0674061586
  • 9780674063150
  • 0674063155
Subject(s): Additional physical formats: No titleDDC classification:
  • 614.4/7 23
LOC classification:
  • RA638 .H69 2011
NLM classification:
  • 2012 B-936
  • QW 11 AA1
Online resources:
Contents:
Disease, security, and vaccines -- Historical patterns of vaccine innovation -- Vaccine development during World War II -- Wartime legacies -- The end of an era -- Biodefense in the 21st century -- The search for sustainable solutions.
Summary: Historically, the US has excelled at responding to national health emergencies and developing new or improved vaccines, often in time to meet the objectives of particular military missions. However, probing vaccine development for factors that foster timely innovation found it has been falling, not rising since WWII. Ironically, the biotechnology industry boom and the rise of specialization and outsourcing has undercut the collaborative networks and research practices that drove successful vaccine projects in the past. The author's investigation teaches important lessons for our efforts to rebuild 21st century biodefense capabilities, especially when the financial payback for a particular vaccine is low, but the social returns are high.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Books Books Odessa College Stacks 614.47 H869L (Browse shelf(Opens below)) 1 Available 51994001659558
Browsing Odessa College shelves, Shelving location: Stacks Close shelf browser (Hides shelf browser)

Includes bibliographical references and index.

Disease, security, and vaccines -- Historical patterns of vaccine innovation -- Vaccine development during World War II -- Wartime legacies -- The end of an era -- Biodefense in the 21st century -- The search for sustainable solutions.

Historically, the US has excelled at responding to national health emergencies and developing new or improved vaccines, often in time to meet the objectives of particular military missions. However, probing vaccine development for factors that foster timely innovation found it has been falling, not rising since WWII. Ironically, the biotechnology industry boom and the rise of specialization and outsourcing has undercut the collaborative networks and research practices that drove successful vaccine projects in the past. The author's investigation teaches important lessons for our efforts to rebuild 21st century biodefense capabilities, especially when the financial payback for a particular vaccine is low, but the social returns are high.

There are no comments on this title.

to post a comment.